Pulmonary carcinosarcoma (PC) is a rare and highly malignant type of non-small cell lung cancer (NSCLC) that is insensitive to radiotherapy and chemotherapy and has a poor prognosis. Here, we report a case of an 88-year-old patient with inoperable PC and a history of cerebral infarction who was treated with first-line anlotinib combined with stereotactic body radiation therapy (SBRT). The therapeutic response has sustained for 10 months. Our work suggests that SBRT combined with anlotinib may be a safe and effective treatment strategy for octogenarians with PC.
CITATION STYLE
Liang, L., Chen, T., Ren, T., Mao, M., Wang, K., Tang, C., … Li, T. (2022). First-Line Anlotinib Combined with Stereotactic Body Radiation Therapy for an Octogenarian with Pulmonary Carcinosarcoma. Cancer Management and Research, 14, 103–106. https://doi.org/10.2147/CMAR.S344149
Mendeley helps you to discover research relevant for your work.